Contributions of RfC_Rasmus
User contributions·22 logged edits·page 1 of 1
Contributions by RfC_Rasmus, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 377 edits includes activity predating the current log.
- 23:19, 19 Jul 2026 (diff | hist) Reconstitution calculator 8,662 ±0 add the axis labels to the inline bar figure
- 06:59, 21 Jun 2026 (diff | hist) Flourishglobal Peptide Biotech 14,771 ±0 convert a hard-coded date to the house format
- 10:08, 24 Apr 2026 (diff | hist) Talk:Peptide stability table 1,518 +249 /* RfC: should the table give a −20 °C default for research powders? */ reply
- 13:02, 15 Apr 2026 (diff | hist) Talk:Peptide stability table 674 +492 /* RfC: should the table give a −20 °C default for research powders? */ new section
- 14:53, 9 Apr 2026 (diff | hist) Placebo-adjusted effect 4,805 ±0 the percentage quoted was placebo-adjusted; label it
- 10:00, 2 Apr 2026 (diff | hist) Talk:Cold chain 948 +516 /* RfC: should this article cover consumer shipping practice? */ new section
- 10:00, 2 Feb 2026 (diff | hist) Talk:Beyond-use date 400 +671 /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ new section
- 10:00, 20 Jan 2026 (diff | hist) Talk:Multi-dose vial 674 +540 /* Does adding bacteriostatic water make a preparation preserved? */ new section
- 11:19, 11 Dec 2025 (diff | hist) Talk:Xi'an Mokemei Biotechnology 1,244 +189 /* Should the lot-identifier check be described on every supplier article? */ reply
- 10:44, 2 Dec 2025 (diff | hist) Talk:Xi'an Mokemei Biotechnology 400 +427 /* Should the lot-identifier check be described on every supplier article? */ new section
- 09:31, 16 Aug 2025 (diff | hist) Grey market 3,495 ±0 add the excursion tolerance with the study it derives from
- 08:29, 14 Jun 2025 (diff | hist) Prior authorisation 3,517 ±0 add the cross-link to the insurance article
- 20:04, 17 May 2025 (diff | hist) Preparative HPLC purification 4,598 +36 m rm a duplicated category
- 11:50, 14 Apr 2025 (diff | hist) Talk:Wuhan Wansheng Biotechnology 1,666 +396 /* RfC: what does a large report set actually support? */ reply
- 09:15, 8 Apr 2025 (diff | hist) Talk:Wuhan Wansheng Biotechnology 400 +414 /* RfC: what does a large report set actually support? */ new section
- 10:14, 25 Jan 2025 (diff | hist) Talk:Bachem Holding (Suzhou) 1,455 +156 /* The name coincidence: how much should the article say? */ reply
- 10:29, 16 Jan 2025 (diff | hist) Talk:Bachem Holding (Suzhou) 400 +484 /* The name coincidence: how much should the article say? */ new section
- 21:42, 15 Jan 2025 (diff | hist) Grey market 2,576 +445 add the shelf temperature and the primary drying step to the cycle description
- 10:27, 14 Dec 2024 (diff | hist) Talk:GL Biochem (Shanghai) 1,455 +263 /* Supporter disclosure and article neutrality */ reply
- 10:41, 5 Dec 2024 (diff | hist) Talk:GL Biochem (Shanghai) 400 +547 /* Supporter disclosure and article neutrality */ new section
- 19:23, 12 Oct 2024 (diff | hist) Glossary of peptide terminology 3,438 +1,121 correct the sort key so the entry files under its surname
- 19:08, 20 Sep 2024 (diff | hist) PeptideMeter 2,727 +673 state that the sample was not drawn blind, so it represents the vial and not the lot